Ocugen, Inc. Price Today
Ocugen, Inc.
OCGN
Healthcare
$142.37M
๐ฐ
Market Cap
0
๐ธ
Price to Earnings
$-0.3
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Buy Consensus
Buy |
9 |
Strong Buy |
2 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
OCGN Price Forecast Target
0.6 ๐ 5.0 +801%
OCGN EPS Forecast
-0.3 ๐ -0.3 +-15%
Financials
Profit Margin
0 %
Revenue Growth
0 %
Dividend
$ 0
Held Percent
1.5% - Insiders
24.2% - Institutions
74.3% - Public
Major Fund Holders
-
๐ฐ Blackrock Inc. $12.9M
-
๐ฐ Vanguard Group Inc $11.1M
-
๐ฐ State Street Corporation $5.2M
-
๐ฐ Geode Capital Management, LLC $4.0M
-
๐ฐ JP Morgan Chase & Company $2.7M
Stock Ideas
Bill Ackman Portfolio
Bill Ackman, a renowned investor, has established himself as a long-term value investor with a keen eye for short-term price fluctuations. His expertise lies in special situations investments, and his Pershing Square portfolio reflects a highly concโฆDavid Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individโฆMichael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM feโฆStephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at rโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Ocugen, Inc. industry is Biotechnology
The Ocugen, Inc. sector is Healthcare
The Ocugen, Inc. forecasted predicted Price to Earnings PE ratio is -1.9
The Ocugen, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Ocugen, Inc. is $142.37M
There are total of 223112939 float shares with 24.2% held by Institutions and 1.5% held by insiders
The MOcugen, Inc. forecasted Earnings per Share EPS is $-0.3
The Ocugen, Inc. Earnings per Share EPS is -0.3
The Ocugen, Inc. company has $-49757000 gross profits with 0 profit margins
The Ocugen, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Ocugen, Inc. Revenue is $0 with 0 revenue growth
The price target for Ocugen, Inc. stock is $5.0 for the high target and $2.5 for the low target
The consensus analyst recommendations for Ocugen, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Ocugen, Inc. is Buy, with the following breakdown:
- Buy: 9
- Strong Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of Ocugen, Inc. is 3.6
The dividend of Ocugen, Inc. is $0
The dividend yield of Ocugen, Inc. is 0%
The biggest institutional and mutual fund holders of Ocugen, Inc. stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Geode Capital Management, LLC
The Ocugen, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0